AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $74.54
- 52-wk high
- $80.97
- High
- $75.66
- 52-wk low
- $25.25
- Low
- $73.50
- Prev close
- $74.71
Smart money
Earnings
Earnings came in 31.5% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.7M | $2.3M | $1.1M | $1.2M |
| Cost of what it sold | $1.6M | $2.9M | $3.0M | $3.9M |
| Gross profit | $89.0K | -$592.0K | -$1.9M | -$2.8M |
| What it spent | ||||
| Research and development | $27.9M | $30.0M | $43.7M | $54.7M |
| Sales and admin | $23.3M | $18.0M | $20.8M | $29.0M |
| Total operating expenses | $51.2M | $48.1M | $64.5M | $83.6M |
| What was left | ||||
| Operating profit | -$51.1M | -$48.7M | -$66.4M | -$86.4M |
| Profit before tax | -$43.8M | -$41.3M | -$60.2M | -$79.1M |
| Net profit | -$43.8M | -$41.3M | -$60.2M | -$79.1M |
| EBITDA | -$43.4M | -$40.5M | -$59.4M | -$79.1M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
53balanced
20D volatility
48%annualized
52-week range
$25.25$80.97
20D support
News
What the news says
30 articles · 7 days
Coverage is mixed
Tone of tracked coverage
CG Oncology (CGON) director sells 1,000 shares at $74.54
NeutralAug 18CG Oncology (NASDAQ: CGON) insider lines up new stock sale
NeutralAug 17CG Oncology (CGON) sees Foresite Capital report 4.9% beneficial stake via funds
NeutralAug 14
